Brandon Capital
Melbournebrandoncapital.vc
Overview
Brandon Capital is a life sciences venture capital firm that invests in early-stage and emerging biomedical technologies in Australasia, the UK, and the US.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OncoRes Medical | Feb 2026 | Private Equity | Lead |
| NRG Therapeutics | Sep 2025 | Series B | Co-investor |
| Vaxxas | Aug 2025 | Series D | Co-investor |
| Allay Therapeutics | Jun 2025 | Series D | Co-investor |
| PolyActiva | May 2025 | Series C | Co-investor |
Key People
Katharine Giles
Venture Partner
Roberto Solari
Venture Partner
Chris Smith
Partner
Jonathan Tobin
Partner
Melissa McBurnie
Partner Head Of Impact
Robert Sicilia
Head Of Investor Relations
Bob Soh
Senior Investment Manager
Duncan Mackintosh
Senior Investment Manager
Jess Smith
Investment Manager
Katherine Jackman
Investment Manager
Mara Macdonald
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.